-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Vera Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q2 2024.
- Vera Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $3.64M, a 101% increase year-over-year.
- Vera Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $9.39M, a 99.6% increase year-over-year.
- Vera Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $6.02M, a 226% increase from 2022.
- Vera Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $1.85M, a 3.01% increase from 2021.
- Vera Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $1.79M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)